Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 2/2018

01-02-2018 | Review

Epidemiology of hepatitis B in pregnant Iranian women: a systematic review and meta-analysis

Authors: Gholamreza Badfar, Masoumeh Shohani, Marzieh Parizad Nasirkandy, Akram Mansouri, Ghobad Abangah, Shoboo Rahmati, Sanaz Aazami, Ali Soleymani, Milad Azami

Published in: Archives of Virology | Issue 2/2018

Login to get access

Abstract

Perinatal transmission is one of the most common routes of hepatitis B virus (HBV) transmission. This study aims to identify the epidemiological features of HBV among pregnant Iranian women. This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Two authors independently searched several online databases without time limit until May 2017. The databases include Magiran, Iranmedex, SID, Medlib, IranDoc, Scopus, PubMed, Science Direct, Cochrane, Web of Science and Google Scholar. The data were analyzed based on a random-effects model using Comprehensive Meta-Analysis software version 2. Thirty-seven studies were included in the meta-analysis. The prevalence of HBV among pregnant Iranian women was 1.18% (95% CI: 0.09%-1.53%). The prevalence of HBV among pregnant women living in urban and rural areas was 1.60% (95% CI: 0.06%-4.30%) and 1.70% (95% CI: 0.09%-3.2%), respectively. The prevalence of HBV among housewives and working pregnant women was 4.3% (95% CI: 1.4%-12.5%) and 1.2% (95% CI: 0.02%-5.8%), respectively. The risk of developing an HBV infection was significantly associated with illiteracy (p = 0.013), abortion (p = 0.001), blood transfusion (p < 0.001) and addicted spouse (p = 0.045). However, no significant relationship was observed between HBV infection and urbanization (p = 0.65), occupation (p = 0.37), history of surgery (p = 0.32) or tattooing (p = 0.69). Vaccination coverage (receiving at least a single dose) in pregnant women was 9.8% (95% CI: 5.3%-17.5%). The prevalence of HBV among pregnant women is lower than in the general population of Iran. HBV vaccination coverage was low among pregnant Iranian women. Therefore, health policy-makers are recommended to enforce immunization programs for HBV vaccination among high-risk pregnant women.
Literature
1.
2.
3.
4.
Alavian SM, Fallahian F, Lankarani KB (2007) The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis 16(403):6
5.
Kolawole OM, Wahab AA, Adekanle DA, Sibanda T, Okoh AI (2012) Seroprevalence of hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria. Virol J 9:317CrossRefPubMedPubMedCentral
6.
Jonas MM (2009) Hepatitis B and pregnancy: an underestimated issue. Liver Int 29(Suppl 1):133–139CrossRefPubMed
7.
8.
Yadegari D, Doaei Sh (1998) A study of prevalence and epidemiological factors at the Hepatitis B in the pregnancy women referral at to Zanjan hospitals. Jo J Zanjan Univ Med Sci 6(25):64–71
9.
Aminzadeh Z, Shabani Shahrbabaky Z, Gachkar L, Sayyadi Anari A, Aminzadeh Z, Sayyadi Anari AR (2004) Frequency of HBsAg positive in pregnant women Rafsanjan in the year 2003. J Rafsanjan Univ Med Sci 3(2):126–133
10.
Moradi B, Ghazizade Sh (2003) Prevalence of HBsAg in pregnant women referred to prenatal clinic of Imam Khomeini in 1999.[Dissertation]. Tehran University of Medical Sciences, Tehran
11.
Ghalenoee M, Aali SH (2003) Evaluation of serum HBsAg positive in pregnant women referred to laboratory in Kerman. [Dissertation]. Kerman University of Medical Sciences, Kerman
12.
Sharifi M, Assefzade M, Lalouha F, Ishtiaq B (2000) Detecting carriers of HBsAg among pregnant women in Qazvin Blood Transfusion Center from 2000 to 2001. In: Proceeding of the 1Th Iranian Congress Virology, Tehran
13.
Aali BSh (1998) The prevalence of HBsAg among pregnant women referred to Kerman maternity hospitals in 1997. J Kerman Univ Med Sci 6(2):89–96
14.
Azami M, Nasirkandy MP, Mansouri A, Darvishi Z, Rahmati S, Abangah G et al (2017) Global prevalence of Helicobacter pylori infection in pregnant women: a systematic review and meta-analysis study. IJWHR 5:30–36CrossRef
15.
Mansouri A, Norouzi S, YektaKooshali MH, Azami M (2017) The relationship of maternal subclinical hypothyroidism during pregnancy and preterm birth: a systematic review and meta-analysis of cohort studies. IJOGI 19(40):69–78
16.
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006–1012CrossRefPubMed
17.
Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA et al (2005) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 54:1–31PubMed
18.
Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L et al (2006) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States-recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 55:1–33PubMed
19.
Von Elm E, Altman DG, Egger M et al (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453–1457CrossRef
20.
Ades AE, Lu G, Higgins JP (2005) The interpretation of random-effects meta-analysis in decision models. Med Decis Mak 25(6):646–654CrossRef
21.
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1(2):97–111CrossRefPubMed
22.
Sterne JAC, Egger M (2001) Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. J Clin Epidemiol 54(10):1046–1055CrossRefPubMed
23.
Mirghaforvand M, Montazam SH, Rafie A (2007) Study of prevalence and contributing factors of hepatitis b among pregnant women referred to laboratory of health center of bonab. J Urmia Nurs Midwifery Fac 5(3):122–127
24.
Salimi S, Alijahan R, Nakhostin B, Hazrati S (2014) Prevalence of HbsAg+ cases and its associated factors in pregnant women referred to health centers of Ardabil District in 2009. J Health. 5(3):248–258
25.
Sarifi-halat B, Kaikha F, Sanei-Moghaddam S, Alavi-Naeini R, Metanat M, Khademi R (2005) Epidemiological study of Hepatitis B surface antigen in pregnant women in Zahedan. Zahedan J Res Med Sci 7(2):119–124
26.
Tabasi Z, Mir Hosseini F, Mousavi SGA, Ghafouri L (2003) HBsAg in parturients referring to gynecologic clinics in Kashan, 2002. KAUMS J (FEYZ). 7(3):35–41
27.
Motazakker M, Shokat Nagadeh M, Khalili F, Shayeri B (2014) Hepatitis B Virus infection among pregnant women attending Health Care Centers of Urmia. J Guilan Univ Med Sci 23(89):45–50
28.
Cheraghali F, Yazarloo S, Behnampour N, Azarhoush R (2011) Frequency of HBsAg in pregnant women in Gorgan, Iran. J Gorgan Uni Med Sci. 13(4):84–90
29.
Kavosi A, Vizvari P, Mohammadi Gh, Jouybari L, Sanagu A (2015) Seroprevalence of positive HbsAg and its associated factors in pregnant women referred to Health Centers of Agh-Ghala City in 2010-2012. IJOGI 18(149):8–16
30.
Mohammad Jaffari R, Saadati N, Vaziri Esfarjani Sh, Soorani Yan Cheshmeh A (2004) A survey of the frequency of HBsAg+ status in pregnant women attending health centers in Ahwaz. Payesh Health Monit 3(3):237–243
31.
Mobaien A, Mohammadian F, Mazloomzadeh S, Esmaeilzadeh A, Sorouri Zanjani R, Savabi S et al (2014) Seroprevalence of Hepatitis B virus among pregnant women referred to Healthcare Centers of Zanjan. J Zanjan Univ Med Sci 22(93):96–104
32.
Behjati Ardekani R, Sharifi N, Mjibiban M (2000) The prevalence of HBsAg-positive in 1904 pregnant women attending obstetrics and gynecology clinics in Yazd. . [Dissertation]. Sadoughi Yazd University of Medical Sciences, Yazd
33.
Mohebbi SR, Sanati A, Cheraghipour K, Rostami Nejad M, Shalmani HM, Zali M (2011) Hepatitis C and Hepatitis B virus infection: epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran. Hepat Mon 11(9):736–739CrossRefPubMedPubMedCentral
34.
Motamedifar M, Amini E, Talezadeh Shirazi P, Sar-vari J (2012) The prevalence of HBsAg and HBsAb among pregnant women referring to Zeynabiyeh Hospital, Shiraz Iran. Shiraz E Med J 13(4):187–196
35.
Ahmadi M, Toghyani R, Shahidi Sh, Izadi M, Merasi M, Agdak P et al (2011) Prevalence of HBsAg and high-risk behaviors in pregnant women referring to Urban Health Centers in Isfahan province. IJNMR 16(1):47–54PubMedPubMedCentral
36.
Jalali P, Rabie S, Falah M (1999) Frequency of HbsAg+ among pregnant women in Hamadanin 1998. [Dissertation]. Hamadan University of Medical Sciences, Hamadan
37.
Hassanjan Roshan M (1994) Rate Hepatitis B in Babol pregnant women in 1994. Nabz 9(6):28–31
38.
Ebrahim Pour S, Khosh Nejad F, Naziri S (1993) Study of HBsAg at the time of delivery in pregnant women in Gynecology Hospital of Tabriz, 1987-89. Med J Tabriz Univ Med Sci 27(19):3–15
39.
Ahansaz M, Bojari (2000) Evaluation of HBsAg positive in pregnant women referring to prenatal ward Dezyani hospital in Gorgan in the first half of 1999. [Dissertation]. Iran University of Medical Sciences, Tehran
40.
Nasri Razin B, Family A (2000) Prevalence of hepatitis B virus surface antigen and facilitating factors for the creation thousands of pregnant women referring to hospital in Mirza Koochak Khan and Iranian Blood Transfusion Organization. In: Proceeding of the 9th congress of infectious diseases, Tehran, December
41.
Aghighi M, Aghighi Z (2000) Study of HBsAg positive cases in pregnant women referring to gynecology clinic during 1995–2000. In: Proceeding of the 9th congress of infectious diseases, Tehran, December
42.
Ryazi Z, Mahmoud Yaghoobi M (2007) Prevalence of hepatitis B in referring to the maternity ward of no home dei hospital Torbat-Heidaryeh in the first half of 2004. In: Proceeding of the 9th congress of infectious diseases, Tehran, October
43.
Moradi HR, Razin B, Khataee A, Talebia A (2000) Frequency of hepatitis B surface antigen (HBsAg)and facilitating factors studied 1,000 pregnant referred to blood transfusion organization. [Dissertation].Shahid Beheshti University of Medical Sciences, Tehran
44.
Sahaf F, Tanomand A, Montazam H, Sany AA (2007) Seroprevalence of Hepatitis C, Hepatitis B and HIV and co-infections among pregnant women: a retrospective study in 2006 at Malekan City, Iran. J Res Med Sci 1:138–141
45.
Shoghli A, Nabavi SM, Alavian SM et al (2014) Hepatitis B surface antigen prevalence in pregnant women: a cross-sectional survey in Iran. Int J Prev Med 5(Suppl 3):S213–S218PubMedPubMedCentral
46.
Dehghani Zahedani M, Azinfar A, Mahouri K, Mehrdad S (2010) The identification of related risk factors of thyroid disorder in an iranian pregnant population. Iran J Endocrinol Metab 12(4):352–358
47.
Afzali H, Momen Heravi M, Moravveji SA, Poorrahnama M (2015) Prevalence of Hepatitis B surface antigen in pregnant women in Beheshti Hospital of Kashan, Isfahan. Iran Red Crescent Med J 17(7):e20598CrossRefPubMedPubMedCentral
48.
49.
Bayani M, Biazar T, Hasanjani Roushan M, Bayani F, Siadati S (2016) The effect of Hepatitis B vaccination at birth on reducing the prevalence of Hepatitis B surface antigen among rural pregnant women in Babol, Iran. J Babol Univ Med Sci 18(1):7–10
50.
Kheiri L, Makvandi S (2015) The prevalence of Hepatitis B surface antigen (HBsAg) and its influencing factors in pregnant women referring to Healthcare Centers of Dehloran, Iran in 2011-2012. J Midwifery Reprod Health 3(3):424–429
51.
52.
Bayo P, Ochola E, Oleo C, Mwaka AD (2014) High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern Uganda. BMJ Open 4(11):e005889CrossRefPubMedPubMedCentral
53.
Luuse A, Dassah S, Lokpo S, Ameke L, Noagbe M, Adatara P et al (2016) Sero-prevalence of Hepatitis B surface antigen amongst pregnant women attending an Antenatal Clinic, Volta Region, Ghana. J Public Health Africa 7(2):584
54.
Murad EA, Babiker SM, Gasim GI, Rayis DA, Adam I (2013) Epidemiology of hepatitis B and hepatitis C virus infections in pregnant women in Sana’a, Yemen. BMC Pregnancy Childbirth 13(1):127CrossRefPubMedPubMedCentral
55.
Kirbak ALS, Ng’ang’a Z, Omolo J, Idris H, Usman A, Mbabazi WB (2017) Sero-prevalence for Hepatitis B virus among pregnant women attending antenatal clinic in Juba Teaching Hospital, Republic of South Sudan. Pan Afr Med J 26:72PubMedPubMedCentral
56.
Dionne-Odom J, Mbah R, Rembert NJ et al (2016) Hepatitis B, HIV, and syphilis seroprevalence in pregnant women and blood donors in Cameroon. Infect Dis Obstet Gynecol 2016:4359401CrossRefPubMedPubMedCentral
57.
Porolajal J, Majdzadeh R (2009) Prevalence of chronic Hepatitis B infection in Iran. IRJE 4(3 and 4):1–8
58.
Sayehmiri K, Azami M, Darvishi Z, Nikpay S, Borji M (2016) The prevalence of hepatitis B infection in health care workers in Iran—a systematic review and meta-analysis. Iran J Public Health 45(2):7
59.
Mohammadi Z, Keshtkar A, Eghtesad S, Jeddian A, Pourfatholah AA, Maghsudlu M et al (2016) Epidemiological profile of Hepatitis B Virus Infection in Iran in the past 25 years; a systematic review and meta-analysis of general population studies. Middle East J Dig Dis. 8(1):5–18CrossRefPubMedPubMedCentral
60.
Molijn MHJ, Van der Linden JM, Ko LK, Gorgels J, Hop W, Van Rhenen DJ (1997) Risk factors and anti-HBc reactivity among first-time blood donors. Vox Sang 72(4):207–210CrossRefPubMed
61.
Sayehmiri K, Azami M, Nikpey S, Borji M, Sayehmiri F (2015) Hepatitis B vaccination coverage in health personnel of iran: a systematic review and meta-analysis study. IRJE 11(3):1–10
62.
Azami M, Borji M, Ghanbari F, Nikpay S, Sayehmiri K (2015) Hepatitis B vaccination coverage of physicians and nurses in Iran: a systematic review and meta-analysis study. J Birjand Univ Med Sci 22(4):304–315
63.
Azami M, Sayehmiri K, Darvishi Z, Sayehmiri F (2015) Hepatitis B vaccination coverage among dentists in Iran: a systematic review and meta-analysis study. Hepat Mon 15(83):37
64.
Azami M, Nikpey S, Pakzad I, Sayehmiri K (2016) Effects of immunization to hepatitis B vaccine in Iranian health staff: a systematic review and meta-analysis study. Koomesh 17(4):789–795
65.
Azami M, Hafezi Ahmadi MR, Sayehmiri K (2017) Hepatitis B vaccination efficacy in Iranian healthcare workers: a meta-analysis study. Hepat Mon 17(1):e37781
66.
Ephraim R, Donko I, Sakyi SA, Ampong J, Agbodjakey H (2015) Seroprevalence and risk factors of Hepatitis B and Hepatitis C infections among pregnant women in the Asante Akim North Municipality of the Ashanti region, Ghana; a cross sectional study. Afr Health Sci 15(3):709–713CrossRefPubMedPubMedCentral
67.
Akani CI, Ojule AC, Opurum HC, Ejilemele AA (2005) Sero-prevalence of hepatitis B surface antigen (HBsAg) in pregnant women in Port Harcourt, Nigeria. Niger Postgrad Med J 12(4):266–270PubMed
Metadata
Title
Epidemiology of hepatitis B in pregnant Iranian women: a systematic review and meta-analysis
Authors
Gholamreza Badfar
Masoumeh Shohani
Marzieh Parizad Nasirkandy
Akram Mansouri
Ghobad Abangah
Shoboo Rahmati
Sanaz Aazami
Ali Soleymani
Milad Azami
Publication date
01-02-2018
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 2/2018
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3551-6

Other articles of this Issue 2/2018

Archives of Virology 2/2018 Go to the issue

Original Article

Analysis of the glycoproteins of Seoul orthohantavirus strain B1 associated with fusion activity

Brief Report

First molecular identification of kobuviruses in wolves (Canis lupus) in Italy

Brief Report

High genetic diversity of porcine enterovirus G in Schleswig-Holstein, Germany

Annotated Sequence Record

Characterization of the complete genome of euonymus yellow vein associated virus, a distinct member of the genus Potexvirus, family Alphaflexiviridae, isolated from Euonymus bungeanus Maxim in Liaoning, Northern China

Brief Report

Two alphapartitiviruses co-infecting a single isolate of the plant pathogenic fungus Rhizoctonia solani

Brief Report

Rapid visual detection of lily mottle virus using a loop-mediated isothermal amplification method
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits